HIV‐1 subtypes in Spain: a retrospective analysis from 1995 to 2003

HIV Medicine - Tập 6 Số 5 - Trang 313-320 - 2005
Eva Lospitao1, Amparo Álvarez, Vincent Soriano, África Holguín
1Infectious Diseases Service, Hospital Carlos III, Madrid, Spain.

Tóm tắt

ObjectiveTo perform a retrospective analysis of all HIV‐1 non‐B variants circulating in Spain from 1995 to 2003 and extend their virological characterization.MethodsSamples from a total of 396 HIV‐infected subjects with epidemiological suspicion of being infected with non‐B clades were analysed during the study period. Subtyping was carried out on the protease (PR), reverse transcriptase (RT) and envelope (env) genes.Results PR sequences belonging to non‐B subtypes were recognized in 43.2% of cases (23A, 13C, 6D, 3F, 118G, 3H, 4J and 1U). Subtype G and AG recombinants were the most frequent variants (69%), and were found most often in subjects from West and Central Africa. Up to 70% of pol (PR, RT) sequences belonging to subtype G harboured env sequences belonging to clade A (55%), B (13.8%) or K (3.4%). Nearly half were mosaic GA viruses, and a few were CRF14_BG viruses. Up to 14 new recombinant viruses, which could not be assigned to previously described circulating recombinant forms (CRFs), were found.ConclusionsThere is great diversity in the HIV‐1 variants and recombinant viruses circulating in Spain. Non‐B sequences may be underestimated if only the env region is examined in phylogenetic analyses. Drug resistance testing provides the advantage of pol subtyping, and its additional use for this purpose should be encouraged.

Từ khóa


Tài liệu tham khảo

Peeters M., 2000, HIV Sequence Compendium, 54

Kuiken C, 2001, HIV Sequence Compendium, 283

10.1089/08892220050140946

10.1089/088922200309179

10.1128/JCM.39.5.1850-1854.2001

10.1097/00002030-200205240-00010

10.1089/088922202317406682

10.1310/9X1G-MJ6L-PBJN-1PVE

10.1002/jmv.20280

10.1089/088922200750054693

10.1097/00002030-200109280-00031

10.1002/jmv.10368

Thomson M, 2001, HIV‐1 genetic diversity in Galicia, Spain, BG intersubtype recombinant viruses circulating among injecting drug users, 15, 509

10.1089/08892220152596560

10.1136/sti.78.1.e1

10.1046/j.1469-0691.2003.00541.x

Esteves A, 2002, Molecular epidemiology of HIV‐1 infection in Portugal, high prevalence of non-B subtypes, 18, 313

10.1097/00002030-200002180-00011

10.1089/088922201750102607

10.1097/00002030-200212060-00012

Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III., 2003, Vigilancia Epidemiológica del SIDA en España, Registro Nacional de casos de SIDA, 2, 1

Laurent C, 2001, Epidemiology of HIV infection in sub‐Saharan Africa, AIDS Rev, 3, 59

10.1086/319752

10.1007/s100960050273

10.1310/7BWP-0X7F-NXNA-QRNP

10.1093/jac/43.2.253

Kantor R, 2003, Polymorphism in HIV‐1 non‐subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution, AIDS Rev, 5, 25

Frater J., 2002, The impact of HIV‐1 subtype on the clinical response on HAART, J HIV Ther, 7, 92

Nicastri E, 2004, Non‐B HIV‐1 subtypes, replicative capacity and responses to antiretroviral therapy, 20, 816

10.1016/S0166-3542(02)00100-6

Montano A, 1997, Divergent transcriptional regulation among expanding HIV‐1 subtypes, J Virol, 71, 8657, 10.1128/jvi.71.11.8657-8665.1997

10.1006/viro.1997.8980

Workshop Report from the European Commission (DG XII, INCO‐DC) and the joint United Nations Programme on HIV/AIDS., 1997, HIV‐1 subtypes: implications for epidemiology, pathogenicity, vaccines and diagnostics, AIDS, 11, 17

10.1097/00002030-200102160-00001

Kern D, 1996, An enhanced‐sensitivity branched‐DNA assay for quantification of HIV‐1 RNA in plasma, J Clin Microbiol, 34, 3196, 10.1128/jcm.34.12.3196-3202.1996

Mulder J, 1994, Rapid and simple PCR assay for quantitation of HIV‐1 RNA, application to acute retroviral infection, 32, 292

10.1016/0166-0934(93)90075-3

10.1089/088922201750252043

10.1097/00126334-200204150-00016

Yahi N, 2001, Use of drug resistance sequence data for the systematic detection of non‐B HIV‐1 subtypes, how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale, 183, 1311

10.1002/jmv.20208

10.1089/088922200309205